+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2012-10-30Number of Pages: 125

Neuromodulation Devices Market - Global Industry Size, Market Share, Trends, Analysis, And Forecast 2012 - 2018

Neuromodulation devices are used to carry out a process by which a neuron uses one or more neurotransmitters to regulate other populations of neurons. Neuromodulation is a physiological process by which nervous activity is regulated by controlling the physiological levels of several classes of neurotransmitters. One of the fastest growing sectors of the medical devices market, the neuromodulation devices market is estimated to reach a value of US$7.1 bn by 2018, expanding at a CAGR of 14.4% in the period from 2012 to 2018.

Neuromodulation devices are used to provide relief to a patient through modulation or alteration of nervous system function. Neuromodulation functions by stimulating the nerves to produce responses that are natural or by the application of small doses of medicines directly at the site where required. Due to an increase in the adoption of minimally invasive treatment options and medical tourism, the market for neuromodulation devices is expected to grow in the next decade. 

The report addresses questions related to the neuromodulation devices market such as the details about the various segments and sub-segments of the neuromodulation devices market, the current and future trends, the growth drivers, and the factors inhibiting the market. Collated by expert market analysts, the study can be used for expansion, competition monitoring, and for investing in the neuromodulation devices market. 

Overview of the Neuromodulation Devices Market

The global neuromodulation devices market is segmented on the basis of technology, application, and geography. On the basis of geography, the global neuromodulation devices market is segmented into Asia Pacific, Europe, North America, and Rest of the World. Out of these regions, North America dominated the market in 2011, accounting for 65% of the global neuromodulation devices market, and being valued at US$1.8 bn. Asia Pacific is expected to expand at a CAGR of over 15% between 2012 and 2018, owing to the rising demand for neuromodulation devices from developing nations. 

The major growth drivers of the global neuromodulation devices market include the rising prevalence of chronic diseases, rising geriatric population, rising vulnerability to acquire diseases such as Parkinson’s and Alzheimer’s, and technological advancements in neuromodulation devices, making them effective as an add-on therapy. The rising prevalence of lifestyle-induced illnesses such as obesity or depression, increase in the demand for minimally invasive surgeries, increasing consumer expenditure, and an increase in the funds to conduct studies are driving the global market for neuromodulation devices. 

The market’s growth is likely to be inhibited by the changing technological landscape, the availability of alternate treatment procedures, and the side effects and risks associated with the use of neuromodulation devices. Other restraining factors include getting FDA approvals and stringent government regulations that may hamper the market for the forecast period. 

Key Players in the Neuromodulation Devices Market:

The leading players in the neuromodulation devices market that have been profiled and analyzed in the report are: Uroplasty, Codman and Shurtleff, Cervel Neurotech Inc., IntraPace, Nevro , Medtronic, Boston Scientific Group, Integra, St. Jude Medical, Neuronetics Inc., and Cyberonics.
 
Segmentation by Technology Type:

  • Spinal cord stimulation medical devices
  • Deep brain stimulation devices
  • Sacral nerve stimulation devices
  • Vagus nerve stimulation devices
  • Gastric electric stimulation devices. 

Segmentation by Application Area:

  • Medtronic’s Spinal Cord and Deep Brain Neurostimulation Systems
  • St. Jude Medical’s Eon Mini Neurostimulator System
  • Boston Scientific’s Precision Spinal Cord Stimulation System
  • Nevro’s Senza System for Spinal Cord Stimulation
  • Cyberonics’ VNS Therapy System
  • Codman & Shurtleff’s Medstream System
  • Medtronic’s Enterra Therapy System
  • IntraPace’s abiliti system.

Segmentation by Geography:

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW). 

This report gives you access to decisive data such as:

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for the coming years 

Key highlights of this report

  • Overview of key market forces propelling and restraining market growth 
  • Up-to-date analyses of market trends and technological improvements 
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors 
  • An array of graphics and SWOT analysis of major industry segments 
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis 
  • Offers a clear understanding of the competitive landscape and key product segments

 

Neuromodulation is one of the fastest growing sectors in the medical devices market. Neuromodulation devices provide symptomatic relief through alteration, or modulation of nerve system function. Neuromodulation functions either by stimulating nerves to produce a natural biological response or by applying small doses of medicines directly to the site of action. The neuromodulation devices market is growing rapidly due to increase in the ageing population resulting in increased demand for newer treatment options for age related diseases. 

 

This market is expected to benefit from the rise in demand for non-invasive treatment options. Advancement in technology and increased knowledge in neurophysiology offers vast potential opportunities in treatment, influencing stupendous growth of the neuromodulation devices market. Neuromodulation market addresses the huge patient population in epilepsy, anxiety disorders, stroke, depression, Parkinson’s disease, and others. With this stupendous growth, neuromodulation market is expected to become as large as the cardiac devices market.

 

Market Segmentation

  • Deep Brain Stimulation (DBS)
  • Transcranial Magnetic Stimulation (TMS)
  • Spinal Cord Stimulation (SCS)
  • Vagus Nerve Stimulation (VNS)
  • Peripheral Stimulation

This research report analyzes this market based on its market segments and major geographies. It includes a comprehensive study of the ongoing market trends, industry growth drivers, restraints, market structure, and market projections for the coming years. The report also includes an analysis of the technological developments in the neuromodulation devices market, Porter’s five force model analysis, and company profiles of the top industry players. It provides a review of the micro and macro factors significant from the point of view of the existing market players and new entrants with value chain analysis. 

 

Major geographies analyzed under this report are North America, Europe, Asia-Pacific, and the Rest of the World.

 

Some of the major players dominating the market of neuromodulation devices are Medtronic, St. Jude Medical, Boston Scientific, Cyberonics, IntraPace, Nevro, Johnson & Johnson, Codman, Integra, and others. 


 
 
Back To Top